Informazioni sul prodotto
- 1 alpha,24-dihydroxycholecalciferol
- 1,24-dihydroxycholecalciferol
- Curatoderm
- Curatoderm
- Bonalfa
- (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,5R)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
- Tacalcitolum
- (5Z,7E)-(1S,3R,24R)-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
- Vellutan
- Apsor
- Vedi altri sinonimi
- (1-alpha,3-beta,5Z,7E,24R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,24-triol
- tv02
- 1a,24-Dihydroxycholecalciferol
- (+)-(5Z,7E,24R)-9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta,24-triol
- 9,10-Secocholesta-5,7,10(19)-triene-1,3,24-triol, (1-alpha,3-beta,5Z,7E,24R)-
- (1?,3?,5Z,7E,24R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,24-triol
- (1R,3S,Z)-5-(2-((1R,3aS,7aR,E)-1-((2R,5R)-5-hydroxy-6-methylheptan-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol
- 1-alpha,24(R)-dihydroxycholecalciferol
- (1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,4R)-4-hydroxy-1,5-dimethylhexyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol
- (1S,3R,5Z,7E,24R)-9,10-Secocholesta-5,7,10-trien-1,3,24-triol
- (1S,3R,5Z,7E,24R)-9,10-Secocholesta-5,7,10-triene-1,3,24-triol
- (1a,3b,5Z,7E,24R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,24-triol
- 1,3-cyclohexanediol, 4-methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,4R)-4-hydroxy-1,5-dimethylhexyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,3S,5Z)-
- 1a,24(R)-Dihydroxycholecalciferol
- 1a,24R-Dihydroxyvitamin D3
- 1α,24R-Dihydroxyvitamin D<sub>3</sub>
- 57333-96-7
- 9,10-Secocholesta-5,7,10(19)-triene-1,3,24-triol, (1α,3β,5Z,7E,24R)-
- Pri 2191
- Tv 02
Proprietà chimiche
Richiesta tecnica su: IN-DA00EBMC Tacalcitol
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.